31 Dec 2018 07:00
Croda International Plc ("Croda")
Acquisition of leading global vaccine adjuvant specialist
Further to the announcement on 17 December 2018, Croda has now completed the acquisition of Brenntag Biosector A/S ('Biosector') from Brenntag Nordic A/S on 28 December 2018. Biosector is a specialist in the manufacture and supply of adjuvants serving both the human and veterinary vaccine markets.
-ENDS-
For enquiries contact:
Investors: | Conleth Campbell, VP Investor Relations, Croda | +44 1405 860551 |
Press: | Charlie Armitstead, Teneo | +44 7703 330269 |